Compare Amphastar Pharmaceuticals Inc (AMPH) vs ProShares Ultra Bloomberg Natural Gas ETF (BOIL) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

BOIL trades at $22.68, down 4.22% in the past 24 hours amid a bearish technical outlook with moving averages signaling strong selling pressure. The stock recently underwent a 1:2 split on May 28, 2026. Key support lies at $21, with resistance at $25. Recent news highlights shareholder meeting results and natural gas market volatility influencing sentiment.

Outlook remains cautious due to weak technicals and external commodity pressures. Investment opportunities hinge on natural gas price rebounds, but risks include sustained bearish trends and energy market fluctuations. Investors should weigh technical recovery signals against fundamental exposure to volatile energy sectors.